Fundraising Fox

Eyenuk

Woodland Hills, US · Founded 2013 · Delaware corporation · 1 known investors

eyenuk.com

Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs. Its technology holds regulatory clearances such as a Class IIb CE mark under EU MDR and maintains SOC 2 Type 2, HIPAA, and GDPR compliance.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

KS
Kaushal SolankiDirector
GA
Gaurav AgarwalExecutive Officer, Director
MD
Mads DallDirector
ZA
Zina Affas BesseDirector
ML
Marie-Louise LittleDirector

Investors · 1

Competitors · 7

by search overlap

Companies competing with Eyenuk for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$5.6MraisedJun 2026 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gaurav AgarwalExecutive Officer, Director
  • Mads DallDirector
  • Zina Affas BesseDirector
  • Marie-Louise LittleDirector
  • Kaushal SolankiDirector
Offering amount
$5.6M
Amount sold
$5.6M
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$22.4MraisedAug 2022 · 27 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank ChengExecutive Officer
  • Zina Affas BesseDirector
  • Kaushal SolankiExecutive Officer, Director
  • Marie-Louise LittleDirector
  • Manish PottiDirector
  • Robert BinneyDirector
Offering amount
$26.9M
Amount sold
$22.4M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedMay 2018 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin CoyneDirector
  • Kaushal SolankiExecutive Officer, Director
  • Manish PottiDirector
Offering amount
$4M
Amount sold
$3M
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.4MraisedNov 2017 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Manish PottiDirector
  • Martin CoyneDirector
  • Kaushal SolankiExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.4M
First sale
Oct 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedJul 2016 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kaushal SolankiExecutive Officer, Director
Offering amount
$2.3M
Amount sold
$1.5M
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 15 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$300K
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$224.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$218.6K
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$216.4K
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$1M
National Institutes of Health (NIH)National Institutes of HealthPhase I2015$225K
National Institutes of Health (NIH)National Institutes of HealthPhase IISTTR2014$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2014$788.7K
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$217K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$399.4K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2012$260.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news